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1. INTRODUCTION 
 
1.1 Neurogenesis 
 Neurons are electrically excitable cells that process and transmit information through 
electrical and chemical signals. Neurons are, together with glial cells, the core components of 
the brain and spinal cord of the central nervous system. Both neurons and glial cells are 
generated from neural stem cells and progenitor cells in a process called neurogenesis that 
occurs during embryonic and perinatal stages as well as throughout adult life in restricted 
brain regions (Ming and Song, 2011). Neurogenesis is regulated by the dynamic interplay 
between transcription factors, epigenetic control, microRNA (miRNA) regulators, and cell-
extrinsic signals from the “niche” where stem cells reside (Shi et al., 2008). 
Early neurogenesis begins with segregation of the neural plate from the ectoderm of 
the trilaminar embryo by folding to form the neural groove, which then fuses to form the 
neural tube and the associated neural crest. Later neurogenesis in the central nervous system 
is the proliferation of ventricular neural stem cells, differentiation, migration and lamination 
of the developing neural system (Hill, 2016). Adult neurogenesis is spatially restricted to two 
“neurogenic” brain regions, the subgranular zone (SGZ) in the dentate gyrus of the 
hippocampus where new dentate granule cells are generated, and the subventricular zone 
(SVZ) of the lateral ventricles where new neurons are generated and then migrate to the 
olfactory bulb to become interneurons (Gage, 2000). 
Neurons are postmitotic cells, meaning that they are not capable of proliferation. 
Furthermore, given the fact that neurons are dying in neurodegenerative diseases, such as 
Alzheimer’s, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS), and that adult 
neurogenesis is restricted only to SGZ and SVZ, there is a big interest in differentiating 
induced pluripotent stem cells into different types of functional neurons in vitro, that could be 
used as a substitute for the degenerated ones as well as disease models to understand better 
the pathology. 
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1.2 Induced pluripotent stem cells 
Induced pluripotent stem cells (iPSCs) are a specific kind of pluripotent stem cells 
that can be generated from adult cells. The method to generate iPS cells from mouse 
fibroblasts was discovered by Shinya Yamanaka’s group, when they showed that only four 
specific genes encoding transcription factors (Oct4, Sox2, Klf4 and c-Myc) can reprogram 
adult cells to a pluripotent stem cell state (Takahashi and Yamanaka, 2006.). The same was 
shown for human fibroblasts the year after (Takahashi et al., 2007). The generation of such 
iPS cells can be described in a few steps. First, fibroblasts are collected from the adult 
organisms. Then, four reprogramming transcription factors Oct4, Sox2, Klf4 and c-Myc are 
introduced into the cultured somatic cells. The cells are maintained under embryonic stem 
cell conditions and a small fraction becomes iPS cells after few weeks. The new generated 
iPS cells can then be extracted, expanded and finally differentiated into various cell types 
from all three germ layers, including neurons. 
 
1.2.1 Inducible Neurogenin iPS cells 
In vivo, neuronal differentiation is a complex mechanism involving many 
transcription factors and regulating cascades (He & Rosenfeld, 1991). Most protocols for the 
neuronal differentiation imitate developmental steps by applying stepwise environmental 
perturbations to cells and push them from one developmental step to the next. However, these 
differentiation protocols with multiple steps are never optimal and require months to be 
completed. Furthermore, they often show a high variability and low yields of generated 
neurons. To simplify the neuronal differentiation protocols and help to elucidate the gene 
regulatory mechanisms of stem cell-derived neurons, a special rapid and robust 
differentiation protocol was developed that leads to highly homogeneous neurons (Busskamp 
et al., 2014a). A bicistronic doxycycline-inducible Neurogenin1/2 expression cassette was 
delivered into human iPS cells by a lentiviral system and led to a stable and small molecule-
inducible Neurogenin iPS cell line (iNGN cell line). The induction relies on a tet-on system: 
when doxycycline is added to the medium, Neurogenin-1 and Neurogenin-2 are expressed. 
This results in a homogeneous population of functional bipolar neurons within four days 
(Figure 1). 
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Figure 1. Doxycycline activates transcription of Neurogenin1/2 transcription factors which leads to 
the iNGN differentiation to bipolar neurons within 4 days. iNGN cells lose their self-renewing 
capacity 2 days after adding Doxycycline and become post-mitotic (Busskamp et al., 2014a). 
  
Furthermore, it is known that networks of key transcription factors and miRNAs are 
involved in the neuronal differentiation of iNGN cells. During the differentiation of iNGN 
cells, their miRNA profile changes. On day 0, the uninduced iNGN samples have miRNA 
signatures of stem cells with the miR-302/367 cluster dominating their profile. In contrast, on 
day 4 a neuronal signature with miR-124, miR-96 and miR-9 being the most abundant ones is 
present (Figure 2). Those changes suggest that miRNAs are important during neurogenesis. 
However, their functions are not yet fully understood.  
 
Figure 2. Relative abundance of the miRNA in A) uninduced and B) 4-days differentiated iNGN 
cells. The miRNAs associated with stem cell fate are indicated in blue and the neuronal miRNAs in 
red (Busskamp et al., 2014a). 
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1.3 microRNA 
microRNAs (miRNAs) are short (20-23 nucleotides), non-coding, single-stranded 
RNA molecules that regulate gene expression at the post-transcriptional level (Bartel et al., 
2004). miRNA biogenesis starts in the nucleus where the primary transcripts (pri-miRNAs) 
get transcribed from an intergenic or from an intronic region of the hosting gene by RNA 
polymerase II or III. The pri-miRNA is endonucleolytically cleaved by the nuclear micro-
processor complex formed by the RNase III enzyme Drosha and the Di George critical region 
8 (DGCR8) protein. The two RNase domains of Drosha cleave the pri-miRNA, whereas 
DGCR8 directly and stably interacts with the pri-miRNA and determines its precise cleavage 
site. The resulting precursor miRNA (pre-miRNA) is exported to the cytoplasm by the 
Exporting-5-RAN-GTP and cleaved to the mature miRNA duplex by a complex consisting of 
the ribonuclease Dicer and the transactivator RNA-binding protein (TRPB). The functional 
miRNA strand is embedded into Argonaute (AGO) protein to form the RNA-induced 
silencing complex (RISC). Incorporated in RISC, the miRNA binds to the 3’ untranslated 
region (UTR) of target mRNA in a sequence specific manner, resulting in repression of 
mRNA translation or destabilization of mRNA transcripts through cleavage or deadenylation 
(Figure 3) (Winter et al., 2009). 
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Figure 3. miRNA processing pathway. pri-miRNA is transcribed by RNA polymerase II or III and 
cleaved by the Drosha-DGCR8 complex in the nucleus. The resulting pre-miRNA is exported from 
the nucleus by Exportin-5-Ran-GTP. In the cytoplasm, the RNase Dicer in complex with TRBP 
cleaves the pre-miRNA to its mature length. The mature miRNA is loaded together with AGO 
proteins into the RISC, where it guides the RISC to silence a target mRNAs through mRNA cleavage, 
translational repression or deadenylation (Winter et al., 2009). 
 
Interactions between miRNAs and mRNAs require sequence homology at the 5’ end 
of the miRNA. However, variance in the degree of complementation in the remaining 
sequence allows a single miRNA to target a wide range of mRNAs (50 to >100 mRNAs), 
often regulating multiple genes within a common pathway. One of the pathways for which it 
is known that miRNAs are required is the neuronal development (Ivey et al., 2015). As the 
neurons mature, miRNAs regulate some of the key processes including developmental 
timing, neuronal cell proliferation, neuronal differentiation, cell fate determination, 
synaptogenesis and gliogenesis (Figure 4) (Nampoothiri et al., 2016). However, among the 
hundreds of miRNA identified thus far, only a limited number have been assigned target 
mRNAs and specific functions. 
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Figure 4. miRNAs roles during neuronal development. The same miRNAs are often regulating more 
than one step during neuronal development. Red indicates activated microglia and black squares 
indicate synapses (Cao et al., 2016). 
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1.4 Auxin-based degron system 
In human cells, protein expression can be controlled in many different ways. When 
expression is controlled at the DNA (Sauer et al., 1988) or mRNA levels (Elbashir et al., 
2001), protein depletion is indirect, which is a major limitation for stable proteins as DGCR8, 
as they would persist in cells for long time after disruption of its coding sequence or RNAi 
(RNA interference) mediated mRNA degradation (Busskamp et al., 2014b). Furthermore, 
gene deletion is not reversible and suppression of mRNA accumulation can be insufficient. 
Another way of controlling protein expression is at the protein level itself by using cell-
permeable small molecules that induce posttranslational degradation (Nishimura et al., 2009). 
Plants have evolved a system in which the plant hormone auxin directly induces 
degradation of the AUX/IAA family of transcription repressors by a specific form of the SCF 
E3-ubiquitin ligase (Grey et al. 2001). Auxins are a class of plant hormones that control gene 
expression during plant growth and development (Teale et al., 2006), with indole-3-acetic 
acid (IAA) being the most abundant one. It binds to the F-box transport inhibitor response 1 
(Tir1), which is a part of the SCF (Skp, Cullin, F-box) ubiquitin ligase complex, and 
promotes its interaction with the AUX/IAA transcription repressors. SCF-Tir1 then recruits 
an E2 ubiquitin ligase that polyubiquitylates the repressor resulting in its degradation by the 
proteasome (Figure 5). 
 
Figure 5. Auxin action mechanism based on Tir1. Upon binding of auxin to the Tir1 subunit of the 
SCF complex, their affinity toward the AUX/IAA proteins is enhanced, leading to ubiquitination and 
degradation of the latter in the proteasomes (Da Costa et al., 2013). 
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Human cells lack the auxin response but share the SCF degradation pathway, which is 
why it is possible to implement the system from the plants and use a small molecule auxin to 
conditionally control protein stability. Therefore, Tir1 protein has to be introduced and the 
protein of interest has to be tagged with the auxin responsive domain (so-called auxin 
inducible degron, AID) (Figure 6). The AID system has already been established and it has 
been demonstrated that it promotes degradation of proteins in a variety of human cell lines. 
This applies to degradation of stably expressed GFP in HeLa and HEK293 cells (Nishimura 
et al. 2009), polo-kinase 4 (Plk4), cyclin B1, histone H2B, centromere protein A (CENP-A), 
histone H3, telomeric repeat-binding factor 2 (TRF2) in colorectal cancer cell line DLD-1 
(Holland et al., 2012) and RAD21 and DHC1 in colorectal cancer HCT116 cells (Natsume et 
al., 2016).  
 
Figure 6. AID system used for degrading protein of interest in human cells. Auxin binding to Tir1 
promotes the interaction between Tir1 and the AID degron of the target protein. SCF-Tir1 recruits E2 
ligase resulting in ubiquitination of the AID degron. Finally, the target is degraded by the proteasome 
(Nishimura et al. 2009). 
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1.5 CRISPR/Cas9 technology 
Clustered Regularly Interspaced Short Palindrome Repeats (CRISPR) and variable 
arrays of the CRISPR-associated (Cas) genes constitute archaeal and bacterial mechanism of 
defence against invading phages and plasmids that functions analogously to the eukaryotic 
RNA interference systems (Barrangou et al., 2007). In 2012, Charpentier and Doudna 
highlighted the potential to exploit this bacterial immune system for RNA-programmable 
genome editing. Since then, CRISPR/Cas9 technology has been widely used in biology, 
biotechnology and biomedicine.  
When utilized for genome engineering, this system includes Cas9 endonuclease and 
single guide RNA (gRNA) along with an optional section of DNA repair template. gRNA 
binds to the complementary sequence in the genome and targets Cas9 endonuclease to 
introduce double strand break (DSB) next to the protospacer adjacent motif (PAM) sequence. 
Therefore, gRNAs are synthesized to recognize gene sequences having a PAM sequence at 
the 3’end (5’-NGG-3’) (Cong et al., 2013; Mali et al., 2013) (Figure 7). 
 
Figure 7. CRISPR/Cas9 mechanism of action. Cas9 enzyme (blue) generates breaks in double-
stranded DNA by using its two catalytic centers to cleave each strand of a DNA target site next to a 
PAM sequence (orange) and matching the 20-nucleotide sequence of the single guide RNA (green) 
(Charpentier and Doudna, 2014).  
 
The Cas9-introduced DSB can be repaired with non-homologous end joining (NHEJ) 
that is error prone and usually introduces insertion or deletion (indel) mutations often 
resulting in the knock-out of the targeted gene. If there is a DNA repair template present that 
carries enough homology, homologous recombination (HDR) will occur and the gene of 
interest will be knocked-in at the DSB (Figure 8). 
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Figure 8. Gene editing after the DSB repair. DSBs induced by Cas9 can be repaired in one of two 
ways. In the error-prone NHEJ pathway, the ends of a DSB are processed by DNA repair machinery 
and rejoined, which can result in random indel mutations leading to frameshifts and creation of a 
premature stop codon. Alternatively, a repair template can be supplied to HDR, which allows precise 
editing (Ran et al., 2013). 
 
1.6 Hypothesis 
The hypothesis of the study is that depletion of the most active miRNAs during the 
four days differentiation of iNGN cells to neurons can reveal unknown miRNA functions 
during neurogenesis. Therefore, the aim is to establish the AID system in iNGN cells using 
CRISPR/Cas9 system, for the inducible disruption of the miRNA processing machinery by 
eliminating DGCR8 protein. 
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2. MATERIALS AND METHODS 
 
2.1 MATERIALS 
 For this study, iNGN C4 cell line was used. iNGN is the Personal Genome Project iPS 
cell line, derived from Participant #1 (PGP1, hu43860C) (Coriel, USA) genetically modified 
by lentiviral gene transfer and genomic integration of the doxycycline-inducible Neurogenin 
and rTA3 vectors (Busskamp et al., 2014a). One Shot® Stbl3™ Chemically Competent E. 
coli (Thermo Fisher Scientific, USA) derived from the HB101 E. coli strain, was used for 
cloning. The transformation efficiency of the Stbl3 chemically competent cells is greater than 
1 × 108 cfu/µg plasmid DNA. Validation of the CRISPR/Cas9 set-up was done in human 
embryonic kidney cells 293T (HEK293T) because of their high transfection efficiency.  
 
2.2 METHODS 
2.2.1 Experimental set-up 
To establish the AID system in iNGN cells for the inducible degradation of the 
DGCR8 protein, cells have to be genetically modified with Tir1 using PiggyBac transposon 
system and the DGCR8 has to be tagged with AID tag together with mKate2 as a fluorescent 
marker using CRISPR-Cas9 technology (Figure 9). 
  
Figure 9. Auxin-based degron system mechanism of action in human cells. In the presence of auxin, 
mTir1 binds to the AID tagged protein of interest and initiates its polyubiqutination by the E2 
ubiquitin ligase leading to degradation in the proteasomes.  
 
 For a knock-in of the AID domain from the system at the 3’ end of the DGCR8 gene, 
the gRNA has to target the Cas9 endonuclease around the DGCR8 stop codon. The AID has 
to be supplied as a repair template surrounded by homologous regions to serve as substrate 
for the HDR pathway (Figure 10). 
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Figure 10. Establishment of an AID system for DGCR8 degradation using CRISPR/Cas9 technology. 
The Cas9-gRNA complex introduces DSB at the 3’ end of the DGCR8 gene. The DSB will be 
repaired with HDR triggered by long left and right homology arms (LH, RH) of the repair template 
resulting in gene knock-in. 
 
2.2.2 PCR reactions 
In all PCR reactions the KAPA HiFi HotStart ReadyMix (Kapa Biosystems, USA) 
and the ProFlex PCR System (Thermo Fisher Scientific, USA) were used. The standard PCR 
mix for the KAPA and the standard PCR conditions for the ProFlex system are shown in 
Table 1 and Table 2. A gradient PCR with annealing temperatures from Tm=58-68 °C was 
performed for each primer pair.  
Table 1. Standard PCR mix for amplifying DNA. 
Component Volume Final concentration 
2X KAPA HiFi HotStart 
ReadyMix 
25 µL 1 X 
10µM forward primer 1.5 µL 0,3 µM 
10µM reverse primer 1.5 µL 0,3 µM 
100 ng template DNA As required 2 ng/µL 
dH2O Up to 50 µL / 
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Table 2. Standard PCR conditions for amplifying DNA. 
Step Temperature  Duration Cycles 
Initial denaturation 95 °C 3 min 1 
Denaturation 98 °C 20 sec 
35 Annealing 60-75 °C 15 sec 
Extension 72 °C 15-60 sec/kb 
Final extension 72  °C 1 min/kb 1 
 
2.2.3 Gel electrophoresis 
The gel electrophoreses were performed with the pre-casted E-GEL EX 1% 
(Invitrogen, USA) and Bolt 4-12% Bis-Tris Plus gels (Thermo Fisher Scientific, USA) or 
with an agarose gel made with UltraPure agarose. The UV-light chamber was used for 
imaging.  
2.2.4 Transformation of DNA in competent bacteria 
One Shot Stbl3 Chemically Competent E. coli (Invitrogen, USA) were thawed on ice 
for 15 min and 25 ng DNA was added by stirring with the pipette. After adding the DNA, the 
bacteria suspension was incubated on ice for 10 min; heat shocked at 42 °C for 45 sec and put 
on ice again for 5 min. For the bacteria to recover from the heat shock, 300 µl of SOC media 
were added and incubated for 1 h at 37 °C and shook 300 rpm. Finally, the suspension was 
plated on a pre-warmed LB-Antibiotic plate and incubated overnight at 37 °C. 
 
2.2.5 Cloning 
2.2.5.1 Gibson assembly 
Gibson assembly (GA) was used for assembling multiple overlapping DNA molecules 
by the concerted action of a 5’ exonuclease, a DNA polymerase and a DNA ligase (GA 
reaction mix) (Gibson et al., 2009). GA primers that contain a 5’ end that is identical to an 
adjacent segment and a 3’ end that anneals to the target sequence were designed using Serial 
Cloner 2.6.1 Software (Serial Basics) (Figure 11). 
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Figure 11. Gibson assembly primers design. Primers containing 5’ end identical to the vector (grey) 
and 3’ end to the insert (yellow) were designed (www.addgene.com). 
PCR was performed with specific GA primers to amplify desired fragments from the 
plasmids (Table 3). PCR products were loaded on an E-GEL EX 1% agarose. After the 
electrophoresis, the right bands were cut from the gel, purified with the QIAquick Gel 
Extraction Kit (Qiagen, Germany) and the DNA concentrations were measured with a 
Nanophotometer P330 (Implen, Germany).  
Table 3. GA primers for the amplification of selected fragments from different vectors and lengths of 
the amplified PCR products.  
Primer PCR template PCR 
product 
Sequence Lenght 
PB09-
EF1a_F 
III-80 – PB09-
TRE-EF1a-TetO 
EF1a 
CGGGGAAAAGGCCTCCACGGCCAA
CTAGTGGATCTGCGATCGCTCCGGT
G 625 
EF1a-
mTir_R 
CCAGCACCTTTCTCTTCTTCTTGGG
GGCGGCGGGGCCCATGGCGGC 
EF1a-
mTir_F 
IV-05-
pCAGGS-NLS-
mTIR-HA-p2A-
mTIR-Puro 
NLS-
mTir-HA-
p2A 
AGAGCCGCCATGGGCCCCGCCGCC
CCCAAGAAGAAGAGAAAGGTG 
1798 
mTir-P2A-
Neo_R 
CGTGCAATCCATCTTGTTCAATCAT
AGGTCCAGGGTTCTCCTCCAC 
mTir-P2A-
Neo_F 
II-53-hCas9 NeoR 
AGACGTGGAGGAGAACCCTGGACC
TATGATTGAACAAGATGGATTG 
852 Neo-
PB09_R 
ATTTTGTAATCCAGAGGTTGATTGT
CGACTCAGAAGAACTCGTCAAGAA
G 
pUC - iNGN C4 cDNA Left CGGCCAGTGAATTCGAGCTCGGTA 1377 
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hom1_F homology 
arm 
CCAGTCAGCATGCAGTTATGTTGCC 
hom1 - 
mKate2_R 
TCACCATGGTGGCGACCGGTGGAT
CCACGTCCACGGTGCACAG 
hom1 - 
mKate2_F 
Right 
homology 
arm 
TGAGCCCCTGTGCACCGTGGACGTG
GATCCACCGGTCGCCACCATG 
1343 
mKate2 - 
AID_R 
CTTTGGGACAGGCACCTCCGGATCC
TCTGTGCCCCAGTTTGCTAGG 
mKate2 - 
AID_F II-65-pmKate2-
H2B 
mKate 
CTCCCTAGCAAACTGGGGCACAGA
GGATCCGGAGGTGCCTGTCCC 
696 
AID - 
hom2_R 
GCCCTGGCCCGTGCCACCTCCCTCA
CTTATACATTCTCAGGTCAAT 
AID - 
hom2_F 
IV-06-
pcDNA5FRTT
O_3xHA-
Venus-
3xminiAID 
miniAID 
AAAGATTGACCTGAGAATGTATAA
GTGAGGGAGGTGGCACGGGC 
204 
hom2 - 
pUC_R 
GCATGCCTGCAGGTCGACTCTAGA
GTTGGTCACACAGGTAGTGAGGGA
AG 
 
Vector III-80-PB09 was digested with SpeI and SalI restriction enzymes (NEB, 
USA). For this reaction, 4 µg of the vector DNA was mixed with 2 µL SpeI and 2 µL SalI in 
2 µL 10 x Cutsmart buffer and 10 µL H2O. Reaction mix was then incubated at 37 °C for 90 
min. The same protocol was applied for the digestion of the II-60-pUC19 with KpnI and 
BamHI (NEB, USA). Digested vectors were loaded on the E-GEL EX 1% agarose and 
purified with QIAquick Gel Extraction Kit. 
For the production of the IV-37-PB09_EF1a_mTir1_HA_p2A_Neo vector (Figure 
12), EF1a, NLS-mTir-HA-p2A and NeoR fragments were mixed with 100 ng III-80-PB09 
vector backbone previously cut with SpeI/SalI at equal molecular ratio. The same procedure 
was applied for left homology arm, mKate, miniAID and right homology arm mixed with II-
60-pUC19 backbone previously cut with KpnI/BamHI for the assemble of the IV-52-
pUC19_DGCR8-3’mKate2_AID (Figure 13). 
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Figure 12. The IV-37 vector important for the introduction of the mTir1 protein into the iNGN cells 
using piggybac transposon system; carrying the mTir1 gene (brown) linked with the P2A sequence to 
the Neomycin resistance gene (orange). 
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Figure 13. The IV-52 assembled for the CRISPR/Cas9 genome engineering; containing mKate2 (red) 
–AID (green) fragment flanked by ~ 1,5 kbp left and right homology arms (blue) important for 
homologous recombination of the tag sequence at the DSB introduced by Cas9 endonuclease  
Afterwards, 5 µl of the combined fragments were added to 15 µl GA reaction mix 
(exonuclease, DNA polymerase and ligase) and incubated at 50 °C for 45 min. 4 µl of 
assemblies were transformed to Stbl3 and plated to LB-Antibiotic plates. On the next day 
four colonies of each GA were picked and separately transferred into a shake tube with 5 ml 
LB-medium with 10 µl Ampicillin (Amp). After overnight incubation, the bacteria 
suspension was spun down at 15000 x g for 20 min and the DNA was extracted using the 
QIAprep Spin Miniprep Kit (Qiagen, Germany) in the QiaCube (Qiagen, Germany). To 
detect the clone with correctly ligated fragments and the fewest point mutations the whole 
inserted sequence of the different clones was analysed. The most appropriate clone was 
transferred to a flask with 50 ml LB-medium and 100 µl Ampicillin and used the next day to 
perform a larger, midi DNA preparation using the Qiagen Plasmid plus Midi Kit (Qiagen, 
Germany). 
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2.2.5.2 Cloning gRNAs into the PX459 vector 
A gRNA was designed using the crispr.mit.edu online platform (Hsu et al., 2013). The 
gRNA with the least number of intragenic off targets and a specific bindings close to the 
DGCR8 stop codon was chosen. For the annealing, 2 µl of the top oligo 
(CACCGTGTGCACCGTGGACGTGTGA) and 2 µl of the bottom oligo 
(AAACTCACACGTCCACGGTGCACAC) were mixed together with 2 µl 10 x T4 ligation 
buffer (Thermo Fisher Scientific, USA), 1 µL T4 polynucleotide kinase (Thermo Fisher 
Scientific, USA) and 13 µL dH2O. Annealing mix was transferred to the ProFlex PCR 
System (Table 4). 
Table 4. PCR conditions for annealing top and bottom gRNA oligo.  
Temperature Ramp rate Time 
37 °C  30 min 
95 °C  5 min 
95 °C-25 °C -5 °C/min  
4 °C  hold 
 
For the digestion of the III-34-pSpCas9(BB)-2A-Puro (PX459) vector, 3 µg of the 
vector was mixed with 2 µl BbsI (NEB, USA) (10U/µL), 5 µl Buffer G (Thermo Fisher 
Scientific, USA) and filled with dH2O up to 50 µl in total. The digestion mix was incubated 
at 37 °C for an hour. After digestion, the vector ends were dephosphorylated by adding 0.5 
µL CIP alkaline phospatase and incubating at 37 °C for an hour. The digested and 
dephosphorylated vector backbone was loaded on the E-GEL EX 1% agarose and purified 
with QIAquick Gel Extraction Kit.  
For the production of the IV-39-PX459_DGCR8-3’_gRNA vector (Figure 14), 100 ng 
purified vector backbone were mixed with 2 µl gRNA oligo hybrid (1:250 diluted) and 5 µl 2 
x Mighty Mix (Takara Bio, USA) and incubated at 16 °C for 30 min. Next, 5 µl of the 
ligation reaction was used for transformation into Stbl3 cells. On the next day, four colonies 
were picked and transferred to 5 mL LB medium with Ampicilin. After overnight incubation, 
bacteria were spun down, and DNA was extracted using the QIAprep Spin Miniprep Kit. The 
DNA concentration was measured and the clones were sent for sequencing. Clone with 
correct gRNA was used for a midi DNA preparation. 
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Figure 14. The IV-39 vector assembled for the CRISPR/Cas9 genome engineering; coding for the 
gRNA (yellow) that guides Cas9 protein (turquoise) to introduce the DSB at the 3' end of the DGCR8 
gene.  
2.2.6 Sequencing analysis 
To ensure that the cloning reactions or CRISPR/Cas9 knock-in  had been successful, 
sequencing samples were prepared using 100 ng/µl plasmid DNA (Mini preparations) or PCR 
product in 15 µl dH2O, mixed with 2 µl sequencing primer previously designed with Primer3. 
Primers Piggybac_for (CAAAACTTTTATGAGGGACAGC), Piggybac_rev 
(AAGAACCCAGTTTGGGAACA) and mTir-P2A-Neo_R were used to sequence the EF1a-
NLS-mTir-p2A-Neo fragment incorporated in III-80-PB09 vector, and primers M13_for, 
M13_rev (standard primers), mKate2_AID_F and hom2_pUC_R for sequencing the LH-
mKate2-AID-RH fragment incorporated in II-60-pUC plasmid. For checking the mKate2-
AID tag knock-in in the genome, primers Seq_mK_AID_for 
(CAGCAGGTGCAGGACATAGTG) and Seq_mK_AID_rev 
(CTTTTCAAAGAAGGGGAAACACAGA) were used. DNA solutions were sent to 
Eurofins for sequencing. Serial cloner was used for analysing and comparing the sequences. 
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2.2.7 Cell culture 
2.2.7.1 Coating of the cell culture well plates 
The attachment and proliferation of iPS cells depends on the cell culture plate surface. 
Therefore, before plating stem cells the plates were coated with Matrigel (Corning, USA). 
One aliquot of Matrigel (approx. 120 µl) was resuspended in 12 ml cold coating medium 
(DMEM + 1% Pen/Strep). After resuspending, 1 ml Matrigel solution was transferred to a 6-
well plate, and distributed equally to guarantee that the complete surface is covered. For 12-
well plate, 0.5 ml of the Matrigel solution was used, for 24-well plate 250 µl, etc. The coated 
plates were incubated at RT for at least 45 min before seeding cells.  
2.2.7.2 Thawing iPS cells 
iNGNs were taken from liquid nitrogen tank and kept on dry ice before thawing in a 
bead bath. Thawed cells were transferred to a 15 ml falcon tube and 6 ml PBS was added 
drop-wise. After spinning down the cell suspension at 1400 rpm for 4 min, the supernatant 
was aspired. The cell pellet was re-suspended in 2 ml mTeSR medium (StemCell 
Technologies, Canada) with Rho kinase inhibitor (ROCKi) (StemCell Technologies, Canada) 
and transferred to a 6-well plate. The plate was placed in the incubator at 37 °C and 5% CO2. 
ROCKi (Y-27632) is a factor that enhances iPSCs survival upon single cell dissociation 
(Watanabe et al. 2007), but has to be removed from the mTeSR medium after 24 h.  
2.2.7.3 Culturing iPS cells 
iNGN cells were cultured on Matrigel-coated well plates in mTeSR medium and kept 
inside the incubator at 37 °C and 5% CO2. When changing the media, mTeSR was aspirated, 
cells were washed once with PBS, and the new mTeSR was added (2 ml for 6-well plate, 1 
ml for 12-well plate, etc.) using serological pipettes.  
Cells were passaged when they reached 70-80% confluence. After washing with PBS, 
the cells were detached using TrypLE Express (Thermo Fisher Scientific, USA) (0.5 ml for 6-
well plate, 250 µl for 12-well plate, etc.) for 5 min at 37 °C. PBS was used for collecting the 
detached cells to a falcon tube. The cell suspension was centrifuged at 1400 rpm for 4 min, 
the supernatant was removed and the pelleted cells were resuspended in 1 ml mTeSR + 
ROCKi for counting. Next, 10 µl of the cell suspension was mixed with 10 µl trypan blue and 
10 µl of the mixture were transferred on a Countess cell counting chamber slide (Thermo 
Fisher Scientific, USA). Slide was inserted in the Countess II FL cell counter and the amount 
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of cells was calculated. Approx. 35000 cells/cm
3
 were used for passaging. After 24 h cells 
were washed with PBS and the fresh medium without ROCKi was added.  
2.2.7.4 Freezing iPS cells 
iNGN cells were washed with PBS, detached using TripLE, washed with PBS again 
and transferred to a falcon tube. Cell suspension was spun down and the supernatant was 
aspirated. Cell pellets were resuspended in mFReSR (StemCell Technologies, Canada) (500 
µl / 1 x 106 cells) and 500 µl were aliquoted in cryotubes that were labelled, put in a freezing 
container at -80 °C for 24 h and transferred to a liquid nitrogen tank afterwards.  
2.2.8 PEI transfection 
HEK293T cells were thawed following the protocol for thawing iNGN cells  and 
plated to cell culture flask (75 cm
2
) in 10 ml media (DMEM + 10% FBS + 1% Pen/Strep). 
After 4 days of propagation, they were detached with 2 ml trypsin and 1.5 x 10
6
 cells were 
passaged to the 6-well plate in 1.5 ml DMEM + 10% FBS. The next day, old DMEM + 10% 
FBS was replaced with 1 mL fresh one. The transfection mix was prepared by mixing 200 µl 
PEI solution (9 µl PEI + 191 µl DMEM) with 200 µl DNA solution (3 µg PX459-DGCR8-
3’gRNA vector DNA in 200 µl DMEM). After 30 min incubation, the transfection mix was 
added drop wise to 293T cells. Cells were selected using 3 µg/µl Puromycin and collected the 
next day.  
2.2.9 T7 endonuclease I assay 
DNA was isolated from the transfected HEK293T cells using Qiagen DNA Blood and 
Tissue Kit (Qiagen, USA) using QiaCube. Primers Gen_for 
(CACTCTGGTTTCACTCCTTGATGA) and Gen_rev 
(TAGCAATTTGAGTTGAGGGTTTCTT), previously designed with Primer3 software, were 
used to amplify a 2945 bp long fragment from the isolated DNA. The desired fragment was 
extracted from the gel after the electrophoresis and purified using Qiagen MinElute PCR 
Purification Kit (Qiagen, USA). The DNA concentration was measured using a 
Nanophotometer P330. Next, 2 µl NEB Buffer 2 (NEB, USA)  was added to 200 ng DNA  
and filled with dH2O up to 19 µl in a PCR tube. A hybridisation reaction was run in the 
ProFlex PCR System (Table 5). 
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Table 5. PCR conditions for the annealing of the PCR products. 
Step Temperature Ramp rate Time 
Initial denaturation 95 °C  5 min 
Annealing 95 °C – 85 °C 
85 °C – 25 °C 
-2 °C /s 
-0.1 °C /s 
 
Hold 4 °C  hold 
 
For the endonuclease digest, 1 µl of T7 endonuclease I was added to the annealed 
PCR products for 15 min at 37 °C. T7 endonuclease recognizes and cleaves non-perfectly 
matched DNA (Gushin et al., 2010). The reaction was stopped by adding 1 µl of 0.5 mM 
EDTA and the samples were analysed on a gel.  
2.2.10 Nucleofection 
Cells were detached with TripLE, spun down and resuspended in mTeSR + ROCKi 
for counting. 800000 cells were resuspended in 100 µL P3 supplement mix, previously 
prepared by mixing 82 µL of P3 Primary Cell 4D Nucleofector X Solution with 18 µL 
Supplement from the P1 Primary Cell 4D-Nucleofector Kit (Lonza, Switzerland). For 
piggyback transformation of iNGN cells with IV-37 (mTir-Neo), the cell suspension was 
transferred to a tube containing 10 µg of IV-37 and 2.5 µg of III-25, coding for transposase. 
On the other hand, for introducing CRISPR/Cas9 system in the iNGN cells, the cell 
suspension was mixed with 8 µg of the IV-39 (gRNA/Cas9) and 1.5 µg of the linear donor 
harbouring long homology arms, PCR amplified from the vector IV-52 (AID-mKate2). 
Samples were transferred to the cuvette and nuclefected with Lonza 4D nucleofector using 
pulse CB-156. After two days of propagation, cells nucleofected with IV-37 were selected 
with 100 µg/ml G418 for a few days, and cells carrying IV-39 with 0.5 µg/ml Puromycin for 
12-16 h.   
2.2.11 Fluorescence activated cell sorting (FACS) 
Cells previously nucleofected with IV-39 (gRNA/Cas9) and linear donor (AID-
mKate) were trypsinised, washed once in PBS and washed again in FACS buffer (PBS + 
10% FBS + 1 mM EDTA). After centrifugation at 1400 rpm for 4 min, cells were 
resuspended in 500 µl FACS buffer for sorting, transferred to FACS tubes and put on ice. 
Before putting them in the BD Aria II cell sorter (BD Biosciences, USA), cells were filtered 
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to remove cell clumps. Gating was done in BD FACSDiva 8.0.1 software. For discriminating 
cell debris from iNGN cells, FSC-A vs. SSC-a plot was used, and for excluding doublets and 
clumps FSC-A vs. FSC-H and SSC-H vs. SSC-W plots. Nucleofected cells positive for 
mKate2 were sorted into the 96-well plate. 
2.2.12 Cell colony picking and genotyping 
To obtain monoclonal lines carrying the mKate2-AID tag, 500 and 1000 FACS sorted 
cells were seeded to a 6-well plate. After 8 days of propagation, single cells formed colonies 
that were big enough for picking under the microscope. The colonies were divided into half 
using a pipette tip. One half was transferred to the new 48-well plate for expansion, and the 
other half to the PCR tubes with 100 µl PBS. The 48-well plate with picked colonies was 
quickly transferred back to the incubator. PCR tubes were centrifuged for 2 min using a table 
top centrifuge and PBS was aspirated.  
 Cells from the PCR tubes were lysed, their proteins denatured and the remaining 
DNA was used as a template for the genotyping. For lysing the cells, 25 µl H2O was added 
and the cell suspension was incubated in a PCR cycler at 95 °C for 10 min. 5 µl of protease K 
(Qiagen, USA) was added to the lysed cells for protein degradation and incubated at 50 °C 
for 60 min, followed by an incubation step at 75 °C for 15 min.  
 The cell lysate was used for genotyping with primers Gen_for and Gen_rev that were 
designed to bind outside of the left and right homology arms (Figure 15). Using these primers 
the monoclonal lines that are homozygous for the mKate2-AID tag can be distinguished from 
the heterozygous clones on the gel. After the PCR reaction, the products were analysed on a 
1% agarose gel followed by electrophoresis. 
 
Figure 15. Primers Gen_for and Gen_rev used for genotyping were designed so that they 
bind outside of the homology arms.  
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2.2.13 Fluorescence microscopy 
Cells were plated on µ-dishes with high glass bottom (Ibidi, USA) and analysed for 
fluorescence under the total internal reflection microscope two days after. Pictures taken 
under the transmission light and in red channel were overlayed and processed using Fiji 
(Schindelin et al., 2012). 
2.2.14 Auxin preparation 
0.1 g IAA was filled up with dH2O to a volume of 1.144 ml in total. IAA solution was 
kept at 14 °C in dark box because it is light sensitive. 1:1000 (500 mM) was used in the 
media. 
2.2.15 Protein isolation 
Cells were scraped with a cold scraper in 300 µl ice-cold RIPA Lysis and Extraction 
buffer (Thermo Fisher Scientific, USA), in 10 ml of which one protease inhibitor tablet 
(Roche, Switzerland) was added in advance, and transferred from the well to an ice-cold tube. 
After 30 min of constant agitation at 4 °C samples were centrifuged at 4 °C for 20 min at 
12000 rpm. Supernatant containing proteins was kept and pellet with cell debris was 
discarded. Protein concentration was measured with BCA protein assay.  
2.2.16 BCA protein assay 
Samples were prepared using Pierce BCA Protein Assay Kit (Thermo Fisher 
Scientific, USA) following manufacturer’s protocol. 200 µl of working reagent, prepared 
using a 50:1 ratio of the kit reagents A:B, was mixed with 10 µl of pre-diluted BSA standards 
and protein samples and incubated at 60 °C for 5 min. Protein concentration was measured 
with a Nanodrop after generating the standard curve. 
2.2.17 Western blot 
Protein samples were thawed on ice and mixed with 10 µl LDS Sample Buffer (4x), 4 
µl Reducing Agent (10x) (Novex, USA) and filled up to 40 µl with dH2O. Samples were 
heated at 95 °C for 5 min and loaded on the Bolt 4-12% Bis-Tris Plus gel, together with 3 µl 
SeeBlue marker. Electrophoresis was run for 25 min on 200 V.  
Blotting was done with an iBlot device (Thermo Fisher Scientific, USA), following 
the manufacturer’s protocol. The pre-casted gel was wetted and placed on the transfer 
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membrane on the bottom stack followed by a water-wet filter paper, top stack and the 
absorbent pad. Program p0 (7 min) was run.  
To prevent unspecific binding, the membrane was incubated in blocking milk (5% 
milk in PBS + 0.1% Tween20) for one hour in a falcon on a rotary module. 1:1000 (3 µl) 
anti-DGCR8 (Abcam, GB)  and 1:5000 (0.6 µl) anti-GAPDH (Cell Signaling Technology, 
USA) antibodies were added to 3 ml milk (1% milk in PBS + 0.1% Tween20). After an 
overnight incubation in antibody solution on a rotary module at 4 °C, membrane was washed 
three times for 10 min in PBST (PBS + 0.1%Tween). The secondary antibody solution was 
prepared by adding 1:10000 (0.3 µl) of dye-labeled anti-rabbit secondary antibody (Li-Cor, 
USA) in 3 ml milk (1% milk in PBST). After an hour of incubation in secondary antibody 
solution in the dark, the membrane was washed 5 times for 10 min in PBST. The Odyssey 
imaging system (Li-Cor, USA) was used for protein detection. 
2.2.18 RNA isolation 
Cells were detached using TripLE and spun down at 1500 x g for 5 min. Pipettes and 
work space were cleaned with RNAzap. Pellets were resuspended in 500 µl Qiazol (Qiagen, 
Thermo Fisher Scientific, USA) and mixed well for homogenisation by pipetting. After 5 min 
of incubation, cell homogenates were added to phase lock tubes previously spun down at 
1500 x g for 30 s. Next, 100 µl chloroform was added and the two phases were mixed by 
shaking for 15 s. The tubes were centrifuged at 10000 x g for 10 min at 4 °C. Subsequently, 
the upper aqueous phases were transferred to the new 2 ml tube. Samples were put into the 
QiaCube according to the protocol sheet, together with the reagents and columns for RNA 
purification from the miRNeasy Mini Kit (Qiagen, USA). The respective program for RNA 
isolation with Dnase digestion was started. 
2.2.19 cDNA synthesis and mRNA RT-qPCR 
Previously frozen RNA samples were thawed on ice. 1 µg of isolated RNA was filled 
up with RNA-free H2O to 10 µl and mixed with 2 µl 10x RT buffer, 0.8 µL 25x dNTPs, 2 µL 
10x random primers, 1 µL reverse transcriptase and 4.2 µL H2O from the AB High Capacity 
cDNA RT Kit (Thermo Fisher Scientific, USA). Instead of 10 µl reaction mix, 10 µl H2O 
was added to the no-RT control. For the reverse transcriptase to transcribe mRNA to cDNA, 
all samples were incubated in the PCR cycler at 25 °C for 10 min, 37 °C for 2 h, 85 °C for 5 
min and 4 °C on hold.  
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After the incubation, cDNA samples were diluted 1:20 and 2 µl of the diluted samples 
were mixed with 6.25 µl Power SYBR green master mix (Applied Biosystems, USA), 0,375 
µl forward and reverse primer and 3.5 µl dH2O in 96-well plate. DGCR8_F 
(GCAGAGGTAATGGACGTTGG) and DGCR8_R 
(AGAGAAGCTCCGTAGAAGTTGAA) primers were used to check the amount of DGCR8 
mRNA in the cells and ß-actin (ACTB), with ACTB_F (CCTCGCCTTTGCCGATCC) and 
ACTB_R (CGCGGCGATATCATCATCC) primers, was used as a reference. The StepOne 
Real-Time PCR machine (Thermo Fisher Scientific, USA) was run under conditions shown 
in Table 6 and and the StepOne software 2.2.2 was used for analysing the data. 
Table 6. qPCR conditions from comparative qPCR program.  
Cycle Temperature 
[°C] 
Time [min : s] 
1 95 10 
[2 95 0:10 
3] x40 60 1 
 
2.2.20 Exiqon cDNA synthesis and Exiqon miRNA RT-qPCR 
First, dilutions were made from the thawed RNA samples so that the RNA 
concentration in each sample is 5 ng/µl. 1 µl of 5 ng/µl RNA sample was then mixed with 
reagents from the Universal cDNA synthesis kit (Exiqon, USA): 1 µl of 5x reaction buffer, 
0.5 µl of enzyme mix and 2 µl RNA-free H2O. In no-RT control samples, 1 µl of RNA was 
mixed with 4 µl RNA-free water. 5 µl in total were incubated at 42 °C for 60 min, 95 °C for 5 
min and at 4 °C on hold.  
After the incubation, 4 µl of 1:80 diluted cDNA samples were mixed with 5 µl of 
Power SYBR green master mix and 1 µl of Exiqon primer mix in 96-well plate. Exiqon miR-
302a, Exiqon miR-103 and Exiqon 5S primer mix were used to check the expression of 
miRNA-302a, miRNA-103 and 5S as the reference. Afterwards, the plate was spun down, 
placed in the StepOne Real-Time PCR machine and the StepOne software was run (Table 
18). 
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3. RESULTS 
 
3.1 Analysis of the transfected HEK293T cells 
To get a first estimate whether the targeting of the 3’ end of the DGCR8 gene with the 
designed gRNA is successful, a T7 endonuclease assay was performed. For this assay, 
HEK293T cells were transfected with the PX459-DGCR8-3’gRNA vector and the 3 kb DNA 
around the expected DSB was PCR amplified. After the digestion of the hybridized PCR 
products with the T7 endonuclease I, 3 bands were visible on the gel (Figure 16). The upper, 
bigger band (≈ 3 kb), that matches the length of the expected PCR product (2945 bp), and 
two smaller bands with less intensity (≈ 1.5 kb) are detectable. A forward primer was 
designed to bind 1552 bp upstream and a reverse primer to bind 1393 bp downstream of the 
desired DSB. Therefore, the upper from the two smaller bands corresponds to the fragment 
upstream of the cut introduced by the T7 endonuclease and the lower one to the downstream 
fragment. This shows that the targeting strategy is working in human cells and the cut can be 
produced close to DGCR8’s stop codon. 
 
 
Figure 16. T7 endonuclease I essay. HEK293T cells were transfected with gRNA targeting DGCR8. 
Genomic PCRs were prepared and tested for CRISPR/Cas9 induced mutations by T7 endonuclease I 
assay. HEK293T cells transfected with PX459 vector show mismatches at the target sites. 
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3.2 Obtaining a homozygous cell line carrying the mKate2-AID tag 
3.2.1 Fluorescence activated cells sorting analysis  
iNGN cells nucleofected with the vector IV-39 (gRNA/Cas9) and the linear donor 
harbouring mKate2-AID tag flanked by homology arms were FACS sorted for the mKate2 
fluorescent tag (Figure 17). Out of 660385 single iNGN cells, 210 were sorted as 
fluorescently labelled, meaning that CRISPR-Cas9 knock-in of the mKate2-AID tag was 
successful. It corresponds to 0.00032% CRISPR-Cas9 knock-in efficiency.  
 
 
 
 
Figure 17. FACS sorted mKate2+ cells after the CRISPR-Cas9 knock-in of the AID-mKate2 tag at 
the 3’ end of the DGCR8 gene. A) FSC-A vs. SSC-A profile. The “cells” gate corresponds to iNGN 
cells discriminated from the cell debris. B) FSC-A vs. FSC-H (left) and SSC-H vs. SSC-W (right) plot 
with light blue iNGN singlets and excluded black cell doublets and clumps. C) SSC-A vs. PE-Texas 
Red-A plot showing mKate2+ cells among all single iNGN cells in control sample (left) and 
nucleofected sample (right). D) mKate2+ cells displayed on a SSC-A vs. FSC-A plot. E) Numbers of 
events in different cell populations. 
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3.2.2 Genotyping of the obtained fluorescent clones 
FACS sorted mKate2+ clones were isolated and the insertion of the mKate2-AID tag 
was checked by genomic PCR with primers that bind outside of left and right homology 
arms. The predicted length of the PCR fragment with mKate2-AID tag was 3848 bp, and 
without 2945 bp. Only the lower bands (≈ 3 kbp) of clones 3, 4, 6, 8, 11, 13, 14, 16, 20, 23 
and 24, were visible, corresponding to the length of the left and right homology arms (Figure 
18). Clones 9, 12, 15, 17 and 22 showed two bands, in which the upper one (≈ 4 kbp) 
matched the length of both homology arms and the mKate2-AID tag and the lower one the 
unaltered locus. Hence, these clones were heterozygous for the tag, meaning that 
CRISPR/Cas9 knock-in occurred at only one of the two DGCR8 alleles present in human 
cells. Clones where only the upper band was present (2, 7, 10, 18 and 19), were presumably 
homozygous clones for the mKate2-AID tag and were further analysed by sequencing. 
 
Figure 18. The genotyping of mKate2+ clones. Genomic PCRs were performed with primers 
designed to bind outside of LH and RH on 24 picked clones. Clones that show only one band are 
homozygous for mKate2-AID tag or for no tag, and clones with two bands are heterozygous. Clones 
2, 7, 10, 18 and 19 seemed to be homozygous for the mKate2-AID tag. 
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3.2.3 Sequencing analysis of the genotyped fluorescent clones 
The sequencing of the clones confirmed the genotyping results that the mKate2-AID 
fragment is successfully knocked-in before the stop codon at the both alleles. Experiments 
were proceeded with clone 19, therefore only results for clone 19 are shown (Figure 19 and 
20). It was possible to distinguish homozygous iNGN clones from the heterozygous by 
comparing sequencing electropherograms (Figure 20 and 21). Furthermore, the sequencing 
indicated the presence of the correct reading frame, i.e. neither frameshift mutations leading 
to a truncated protein, nor any missense mutations were introduced. 
 
Figure 19. The sequencing analysis of the iNGN clone 19. IV-52 donor vector (Seq_1) and sequenced 
iNGN clone 19 (Seq_2) alignment in Serial cloner showed that mKate2-AID tag is present in iNGN 
cells.  
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Figure 20. The sequencing electropherogram of the iNGN clone 19. Only one signal for A, G, C or T 
was present at each position of the sequenced DNA.  
 
 
Figure 21. Difference in the electropherograms between heterozygote and homozygote for the 
DGCR8 knock-out. Two peaks are visible for each base position in the DNA in the heterozygote and 
only one peak in the homozygote.  
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3.2.4 Cell analysis under the fluorescence microscope 
The previously sequenced clone 19 was analysed under the fluorescence microscope 
to localise the tagged DGCR8 protein. The fluorescence was observed, which is another 
confirmation of the successful CRISPR/Cas9 tagging (Figure 22). Furthermore, the 
fluorescence was observed only in the nucleus suggesting that mKate2-AID tag did not 
interfere with DGCR8 nuclear localization signal. 
 
Figure 22. The fluorescence microscopy analysis of the iNGN cells. The clone 19 was positive for the 
mKate2-AID tag (right) and showed fluorescent signal localized in the nucleus.  
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3.3 Testing the auxin-based degron system in the iNGN cells 
After nucleofection of the homozygous cell line carrying mKate2-AID tag with the 
PB09-mTir-Neo, three iNGN cell lines in total called mTirDGCR8, aidDGCR8 and 
degDGCR8 were produced. mTirDGCR8 expresses the Tir1 protein which is a part of the 
SCF ubiquitin ligase, aidDGCR8 expresses the mKate-AID tagged DGCR8 and degDGCR8 
expresses both Tir1 and AID-tagged DGCR8 (Figure 23). 
 
Figure 23. Produced iNGN cell lines. mTirDGCR8 expressing the mTir1 protein and the non-tagged 
DGCR8, aidDGCR8 expressing tagged DGCR8 and degDGCR8 expressing mTir and AID-tagged 
DGCR8 important for auxin-based degron system.  
 
3.3.1 Survival of the cells treated with auxin 
The mTirDGCR8, aidDGCR8 and degDGCR8 iNGN cell lines were treated with 
different IAA concentrations for 24 h (Figure 24). Immediately after adding IAA to the cell 
culture, colour of the cell media changed gradually to more pink with higher IAA 
concentrations because of the pH change. The same IAA concentrations showed no 
differences in the cell death frequency among all three cell lines. Furthermore, the same 
incidence in cell death occured in the un-treated cells and cells treated with 500 mM IAA. 
However, when cells were treated with IAA concentrations higher than 500 mM more 
apoptotic and necrotic (2000 mM IAA and higher) cell death was observed. Therefore, 500 
mM IAA was used for the AID system activation.  
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Figure 24. The mTirDGCR8, aidDGCR8 and degDGCR8 cell lines treated with 500 mM, 1000 mM 
and 2000 mM IAA for 24h. No difference in cell death was observed between controls and cells 
treated with 500 mM IAA, where many more cells died when treated with higher IAA concentrations. 
Scale bar 400 µm. 
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3.3.2 DGCR8 detection  
The cell lines, mTirDGCR8, aidDGCR8 and degDGCR8 were treated with 500 mM 
IAA for 6h and 24h. DGCR8 from the mTirDGCR8 cells and DGCR8-mKate-AID from the 
aidDGCR8 and degDGCR8 were detected by immunoblotting using anti-DGCR8 antibodies 
(Figure 25). DGCR8 as expected appeared lower on the gel (86 kDa) and tagged DGCR8 
higher (119 kDa) because of the AID-mKate2 knock-in, showing that the translation of the 
tagged protein was successful. 500 mM IAA had no impact on the protein abundance in the 
mTirDGCR8 and aidDGCR8 cells after 6h or 24h treatment. DGCR8 was still present in the 
degDGCR8 iNGNs that were not treated with IAA and after 6h treatment. However, 
degradation occurred 24h after adding IAA and less protein was detected. Not expectedly, 
two additional unspecific bands or DGCR8 isoforms appeared in aidDGCR8 and degDGCR8 
iNGNs.  
 
 
Figure 25. Nuclear DGCR8 fused with the AID degron controlled by the AID system in iNGN cells. 
DGCR8 and DGCR8-mKate-AID detected by immunoblotting using anti-DGCR8 antibodies and 
antiGAPDH as a loading control. Degradation of the AID-tagged DGCR8 observed after 24 h 
incubation in 500 mM IAA. 
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3.3.3 DGCR8 expression analysis 
The mRNA RT-qPCR was performed to test for any changes in the DGCR8 
expression levels after auxin treatment among the produced cell lines (Figure 26). The 
mTirDGCR8 and aidDGCR8 were treated with 500 mM IAA for 72 h and degDGCR8 were 
treated for 24, 48 and 72 h. The experiment was performed in triplicates and results were 
normalized to the no IAA sample. In mTirDGCR8 and degDGCR8, the DGCR8 expression 
did not significantly change among IAA-induced and control samples.  For unknown reasons, 
there was a significant increase in 72 h IAA-induced mTirDGCR8 cells. Nevertheless, 
DGCR8 expression levels in the degDGCR8 was not affected by IAA treatment suggesting 
that the degradation occurs only at the protein level. 
 
Figure 26. Relative fold change in DGCR8 expression in mTirDGCR8 and aidDGCR8 treated with 
500 mM IAA for 72 h and degDGCR8 treated for 24, 48 and 72 h. Significant change was observed in 
72 h treated mTirDGCR8. IAA did not affect DGCR8 expression in aidDGCR8 or degDGCR8 
samples. (p<0.01 is shown by **) 
 
3.3.4 miRNA expression analysis 
To investigate the functionality of DGCR8 degradation, the levels of some candidate 
miRNA were assessed by RT-qPCR with and without IAA treatment. It was known that 
miRNA 302-a and miRNA-103 are expressed in iNGN cells. The same cell samples as for 
mRNA RT-qPCR (Figure 26) were used for  Exiqon miRNA RT-qPCR (Figure 27 and 28). 
Tested miRNAs were still present in the cells after adding 500 mM. miRNA-103 did not 
show any significant change in expression and miRNA-302a expression was significantly 
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lowered in treated degDGCR8 cells after 24, 48 and 72 h indicating the reduced DGCR8 
function after IAA treatment. However, the AID system failed to ablate all mature miRNAs. 
 
Figure 27. Relative fold change in miRNA-302a expression in mTirDGCR8 and aidDGCR8 treated 
with 500 mM IAA for 72h and degDGCR8 treated for 24, 48 and 72 h. degDGCR8 treated samples 
showed 50 % reduction in miRNA-302a expression. IAA did not significantly affect mTirDGCR8 and 
aidDGCR8 treated samples (p<0.01 is shown by **). 
 
Figure 28. Relative fold change in miRNA-103 expression in mTirDGCR8 and aidDGCR8 treated 
with 500 mM IAA for 72 h and degDGCR8 treated for 24, 48 and 72 h. IAA did not significantly 
effect expression in any of the treated samples. 
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4. DISCUSSION 
The aim of the study was to establish an AID system in iNGN cells for the inducible 
degradation of the DGCR8 protein that would lead to miRNA depletion in these cells. The 
construction of conditional AID mutants is dependent upon the introduction of two 
components into cells. The first component is the AID tag that is fused to the DGCR8 at the 
endogenous locus and the second component is the auxin responsive protein, mTir. In this 
experiment, I introduced the AID tag at the C-terminus of the DGCR8 protein using 
CRISPR/Cas9 technology and the mTir protein using piggybac transposon system and tested 
the efficacy of the introduced system in iNGN cells. 
4.1 Obtaining a homozygous cell line using CRISPR/Cas9 technology 
For the CRISPR/Cas9 technology, the linear donor DNA coding for mKate2-AID tag 
flanked by approx. 1.5 kbp homology arms was introduced in the iNGN cells. The knock-in 
efficiency was 0.00032%, which is lower than the reported 0,2% HDR efficiency in iPS cells 
(Miyaoka et al., 2016). The reason for very low CRISPR/Cas9 efficiency could be the 
instability of the PCR amplified linear donor in cells because of degradation by exonucleases. 
To improve donor stability, the PCR product could be cloned into a plasmid and used as a 
donor for HDR. Nevertheless, genotyping, sequencing and fluorescence microscopy showed 
that 1,5 kbp homology initiated HDR at the DSB leading to mKate2-AID knock-in at the 
DGCR8 3' end. Synthetic short left and right homology arms can be used instead of long 
sequences, which would lower the possibility of introducing mutations during the cloning and 
lower the number of sequencing reactions needed to verify the bacterial clone without 
mutations. In a recent paper published by Natsume and Kanemaki (2016), more than ten 
endogenous proteins have been successfully tagged with AID using only 175-220 bp 
homology arms. However, they were only used in human cancer cell lines and in mouse 
embryonic stem cells indicating the need to test whether the short-arm donors are efficient for 
CRISPR/Cas9-mediated HDR in human iPS cell lines.  
A diploid human genome contains two alleles of each gene making a homozygous 
knock-in a time consuming process that usually requires more than one transfection. In this 
experiment, one transfection was enough to initiate HDR at both alleles simultaneously. 
Homozygous insertion was found in 6 out of 24 (25%) FACS sorted clones. Using 
fluorescent tag as a marker was useful for localizing tagged DGCR8 but required time for 
cells to propagate before and after FACS sorting. Instead of a fluorescent tag, antibiotic 
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resistance markers can be used. Two donor vectors containing different antibiotic resistance 
markers can be co-transfected, in order to tag both alleles simultaneously by selecting cells in 
the antibiotic presence. In this way, it would be possible to generate aidDGCR8 cell line by a 
single transfection and subsequent propagation. 
Some of the FACS sorted clones were homozygous for the wild type suggesting that 
FACS also captured false-positive cells due to autofluorescence. However, it was possible to 
isolate iNGN cell clones that were homozygous for the tagged DGCR8 as tested by 
sequencing the genomic loci. The expression of the DGCR8-mKate2-AID fusion protein was 
confirmed further by immunoblotting. These data highlights successful application of the 
CRISPR/Cas9 technology for generation of a homozygous knock-in, thus adding the auxin 
degron to endogenous DGCR8.  
4.2 The auxin-based degron system in iNGN cells 
After obtaining a homozygous cell line, the mTir gene was introduced with the piggybac 
system and three cell lines in total were produced, mTirDGCR8, aidDGCR8 and degDGCR8. 
The western blot showed partial degradation of the DGCR8 in degDGCR8 cells after 24h 
treatment in 500 mM IAA suggesting that the introduced auxin-based system in iNGN cells is 
to some extend functional. Therefore, it is likely that mTir binds to AID and initiates its 
ubiquitination and the degradation inside the proteasomes. It is known from previous studies 
that DGCR8 knock-out stem cells retain the phenotype but proliferate slowly and accumulate 
in G1 phase of the cell cycle (Wang et al., 2008). The stagnation in proliferation was not 
detectable, possibly due to the only partial DGCR8 degradation. 
As shown by the transcription analysis of DGCR8, auxin itself did not have any impact on 
DGCR8’s mRNA levels, which was expected because auxin, as a plant hormone, should not 
affect any cellular gene expression process in humans. However, it seemed that the AID 
system in iNGN cells was not efficient enough to degrade DGCR8 after 24 h IAA treatment, 
as shown in previous studies where other proteins were degraded within only 30 min 
(Nishimura et al., 2009). DGCR8 was still present in degDGCR8 that was not treated with the 
IAA meaning that AID system was not activated without adding IAA. Two additional 
DGCR8 isoforms visible on the blot could indicate changes in posttranslational modifications 
of the DGCR8-mKate2-AID protein, which could lower the affinity of the AID for mTir after 
IAA binding. Moreover, it could be that one allele carries a mutation that results in premature 
stop codon and truncated mKate2-AID tag but was not detected by sequencing. 
40 
 
In line that DGCR8 showed partial degradation after 24 h, two typical stem cell miRNAs 
miRNA-302a and miRNA-103 were still expressed although miRNA-302a significantly 
reduced, indicating that DGCR8 function was likely reduced in an IAA-dependent manner 
but incomplete. Exiqon primers are optimised to detect mature miRNA forms and hence it is 
unlikely that pri-miRNA species before DGCR8 processing were detected. It is possible that 
insufficient auxin amounts were added to the cell media. To be able to add higher 
concentrations, the pH of the auxin solution or cell medium has to be additionally buffered 
that it does not result in increased cell death. In addition, the mKate2-AID tag might change 
protein conformation leading to a lowered affinity to mTir in the presence of auxin. The 
mKate2 fluorescence intensity was not very high at FACS sorting suggesting low expression 
levels or an altered protein structure resulting in lower fluorescence. To avoid potential 
changes in conformation, a longer linker sequence (George and Heringa, 2002) can be added 
between DGCR8’s C-terminus and the mKate2-AID tag or alternatively, the mKate2-AID tag 
must be fused to the N-terminus. Drosha binding domain is localized at the C-terminus of the 
DGCR8 (Lee et al., 2006), which could be the reason for the altered protein structure of the 
tag. 
In conclusion, AID system is established but its function is incomplete and has to be 
optimized. Several other conditional degron technologies, which allow for controlling the 
stability of degron-fused proteins by use of a small molecule, have been established 
(Banaszynski et al., 2006; Bonger et al., 2011; Chung et al., 2015; Neklesa et al., 2011) and 
could potentially be used for the DGCR8 degradation instead of the AID system.  
4.3 Assessing miRNA roles during in vitro neurogenesis 
iNGN cells are offering an effective model for studying the functions and mechanistic 
roles of miRNAs in human because their miRNA expression profiles during differentiation 
resemble those in neurogenesis in vivo. Moreover, they are differentiating to neurons through 
the neural progenitor state (Busskamp et al., 2014a). Many different miRNAs are known to 
contribute to neuronal subtype specification in vivo from neural progenitors (rewied by 
Stappert et al., 2015). Therefore, degradation of DGCR8 can be initiated by adding auxin 
before and after iNGN cells reach the progenitor state to see the differences between the 
overall impacts of miRNAs at those two time points during iNGN differentiation to neurons. 
Furthermore, the AID system can be used for studying different miRNAs functions 
during iNGN neurogenesis. miRNAs known to be upregulated during iNGN differentiation 
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can be spiked in the cell environment where there is none present because of the abolished 
processing pathway to rescue the phenotype and to assess their individual functions 
Additionally, different miRNAs can be spiked in at the same time for studying their possible 
interconnections. For example, miRNA-124 and miRNA-9 can be introduced. These 
miRNAs are already known to be neurogenic and can induce direct conversion of fibroblasts 
into neuronal-like cells (Yoo et al., 2011; Ambasudhan et al., 2011; Xue et al., 2013). Upon 
neuronal differentiation, BAF53a (subunit composition of ATP dependent BAF chromatin 
remodeling complex) is replaced by its homolog BAF53b. Ectopic expression of miR-124 
and miR-9 induces the down-regulation of BAF53a, allowing the incorporation of BAF53b 
and neurogenesis (Yoo et al., 2009). Therefore, it would be interesting to see if miRNA-124 
and miRNA-9 would converse the conditional DGCR8 mutant phenotype to the wild type, 
and at what time point during iNGN neurogenesis. A possibility for further analyses could be 
to look for target genes for the different miRNAs that prove to have an impact on 
neurogenesis. Target genes can be found in miRNA databases (Chou, 2016) and their 
expression analysed by a quantitative qRT-PCR reaction.  
4.4 Using miRNAs as tools to modulate neuronal cell fate in vitro 
Considering that miRNAs are emerging as important players during in vivo neuronal 
subtype specification, they could be exploited as additional tools to modulate neuronal cell 
fate decisions in vitro. miRNA-133b and miRNA-132 were shown to have a negative impact 
on the generation of dopaminergic neurons from mouse embryonic stem cells (Kim et al., 
2007; Yang et al., 2012). On the other hand, miRNA-181a and miRNA-125b were found to 
promote the generation of dopaminergic neurons in human neuroepithelial-like stem cells 
(Stappert et al., 2013). A subset of midbrain dopaminergic neurons degenerate in Parkinson’s 
disease and are therefore of particular interest for neuro-regenerative stem cell research. 
Therefore, the miRNAs that could possibly be found to have an impact on iNGN 
neurogenesis can be envisioned as tools to direct the differentiation of pluripotent stem cells, 
as iNGN cells, and derived neural progenitor cells towards medically relevant neuronal 
subtypes. 
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5. CONCLUSION  
The auxin-based degron system for the inducible disruption of the miRNA processing 
machinery showed reduced DGCR8 function in IAA dependent manner. Such results suggest 
that the auxin-based degron system is established in iNGN cells, but nevertheless this system 
has to be further optimized. 
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